The product.
Blood tests to detect neurological conditions - with a set of benefits
-
0.02 ml vs 2-4 ml by standard ELISA
-
100x vs standard immunoassay technology in the market
-
Compatibility with standard lab infrastructure
-
Multiplexing capability to test various markers
Nevarra’s blood test
The commercial application.
Proprietary blood tests to detect neurological conditions, starting with Cerebral Folate Deficiency
Exclusively licensed operating system
The operating system.
FluoBolt Technology by Fianostics, patented and exclusively licensed to Nevarra Labs for all neuro-applications, globally